Shannon L. Devers

CIK: 0002037721

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (39.5%)

Position reduction

Option Exercises (M)18 (41.9%)

Derivative conversions

Awards (A)8 (18.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IONS

IONIS PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (43 total)

IONS
IONIS PHARMACEUTICALS INC
Oct 16, 2026
Sale(S)
Direct
1.4K shares at avg. $43.54$59K
IONS
IONIS PHARMACEUTICALS INC
Oct 15, 2026
Exercise(M)
Direct
2.8K shares-
IONS
IONIS PHARMACEUTICALS INC
Apr 2, 2026
Sale(S)
Direct
6.2K shares at avg. $74.05$459K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Sale(S)
Direct
755 shares at avg. $80.84$61K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Sale(S)
Direct
5K shares at avg. $80.00$402K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Sale(S)
Direct
14.3K shares at avg. $79.11$1.1M
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Exercise(M)
Direct
385 shares at avg. $52.87$20K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Exercise(M)
Direct
7K shares at avg. $32.60$227K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Exercise(M)
Direct
5.5K shares at avg. $34.69$191K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Exercise(M)
Direct
3.5K shares at avg. $37.58$132K
IONS
IONIS PHARMACEUTICALS INC
Mar 3, 2026
Exercise(M)
Direct
3.8K shares at avg. $40.85$154K
IONS
IONIS PHARMACEUTICALS INC
Jan 22, 2026
Sale(S)
Direct
4K shares at avg. $81.34$323K
IONS
IONIS PHARMACEUTICALS INC
Jan 16, 2026
Sale(S)
Direct
8.4K shares at avg. $75.95$634K
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Restricted Stock Unit
Direct
9.7K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Exercise(M)
Direct
17.4K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Performance Restricted Stock Units
Direct
25.8K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Sale(S)
Direct
2.1K shares at avg. $85.36$179K
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Exercise(M)
Direct
3.8K shares at avg. $37.58$144K
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Sale(S)
Direct
3.5K shares at avg. $84.62$293K
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Exercise(M)
Direct
3.5K shares at avg. $32.60$113K
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Sale(S)
Direct
25.5K shares at avg. $85.36$2.2M
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Exercise(M)
Direct
25.5K shares at avg. $56.78$1.5M
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Exercise(M)
Direct
2.1K shares at avg. $32.60$68K
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Sale(S)
Direct
9.3K shares at avg. $84.62$784K
IONS
IONIS PHARMACEUTICALS INC
Jan 7, 2026
Exercise(M)
Direct
9.3K shares at avg. $52.87$490K

		Type	Shares	Price		Ownership
Oct 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	1,357	$43.54	$59,082	Direct
Oct 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	2,820	-	$0	Direct
Apr 2, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	6,193	$74.05	$458,613	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	755	$80.84	$61,032	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	5,030	$80.00	$402,395	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	14,321	$79.11	$1,133,006	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	385	$52.87	$20,355	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	6,951	$32.60	$226,603	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	5,500	$34.69	$190,795	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	3,510	$37.58	$131,906	Direct
Mar 3, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	3,760	$40.85	$153,596	Direct
Jan 22, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	3,977	$81.34	$323,490	Direct
Jan 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	8,353	$75.95	$634,410	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Restricted Stock Unit	9,675	-	-	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	17,377	-	$0	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Performance Restricted Stock Units	25,800	-	-	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	2,101	$85.36	$179,341	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	3,829	$37.58	$143,894	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	3,460	$84.62	$292,785	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	3,460	$32.60	$112,796	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	25,545	$85.36	$2,180,521	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	25,545	$56.78	$1,450,445	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	2,101	$32.60	$68,493	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	9,264	$84.62	$783,920	Direct
Jan 7, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	9,264	$52.87	$489,788	Direct

1-25 of 43 transactions

About Devers Shannon L.

Devers Shannon L. (SEC CIK 0002037721) files insider reports with the SEC as EVP, Chief Human Resources Ofc of IONIS PHARMACEUTICALS INC (IONS).

Signal8 holds 15 ownership filings by Devers Shannon L. (1 Form 3, 14 Form 4), filed between Oct 1, 2024 and Oct 19, 2026. Those filings report 43 transactions, from Sep 29, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Devers Shannon L.'s filings is in CARLSBAD, CA.

Recent filings by Devers Shannon L.

Oct 16, 2026: Open-market sale of IONS shares (Form 4, code S).
Oct 15, 2026: Option exercise of IONS shares (Form 4, code M).
Apr 2, 2026: Open-market sale of IONS shares (Form 4, code S).
Mar 3, 2026: Open-market sales of IONS shares (3 lines, Form 4, code S).
Mar 3, 2026: Option exercises of IONS shares (5 lines, Form 4, code M).

Other insiders filing for IONIS PHARMACEUTICALS INC (IONS)

Swayze Eric, EVP Research
BENNETT C FRANK, EVP, Chief Scientific Officer
O'NEIL PATRICK R., EVP CLO & General Counsel
Monia Brett P, Chief Executive Officer
Birchler Brian, EVP, Corp and Development Ops
Hayden Michael R, Director

How to read Form 4 transaction codes